Positively Sharing

EU approval for ViiV’s Tivicay for children living with HIV

Reading Time: < 1 minute

The EU authorisation makes Tivicay the first integrase inhibitor available as a dispersible tablet for children in this population, ViiV commented in a statement.  Read More

Exit mobile version